Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0000950170-24-062372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | 2024-05-16 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $6.64 | -18.3K | 320.6K | -5% | -$121.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-16 | F | D | 18,280 | $6.64 | 320,573 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units. |